Zoe Alaniz

Publication Activity (10 Years)

Years Active: 2021-2021
Publications (10 Years): 3

Top Topics

Allogeneic Hematopoietic Stem Cell Transplantation

Replacement Therapy

Top Venues

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Jong Bok Lee, Dilshad H Khan, Rose Hurren, Mingjing Xu, Yoosu Na, Hyeonjeong Kang, Sara Mirali, Xiaoming Wang, Marcela Gronda, Yulia Jitkova, Neil MacLean, Andrea Arruda, Zoe Alaniz, Marina Y Konopleva, Michael Andreeff, Mark D Minden, Li Zhang, Aaron David Schimmer
Venetoclax enhances T cell-mediated antileukemic activity by increasing ROS production. Blood 138 (3) (2021)
Hussein A Abbas, Zoe Alaniz, Sean Mackay, Matthew Cyr, Jing Zhou, Ghayas C Issa, Mansour Alfayez, Jairo Matthews, Steven M Kornblau, Elias Jabbour, Guillermo Garcia-Manero, Marina Y Konopleva, Michael Andreeff, Naval G Daver
Single-cell polyfunctional proteomics of CD4 cells from patients with AML predicts responses to anti-PD-1-based therapy. Blood advances 5 (22) (2021)
Hussein A Abbas, Dapeng Hao, Katarzyna Tomczak, Praveen Barrodia, Jin Seon Im, Patrick K Reville, Zoe Alaniz, Wei Wang, Ruiping Wang, Feng Wang, Gheath Al-Atrash, Koichi Takahashi, Jing Ning, Maomao Ding, Hannah C Beird, Jairo T Mathews, Latasha Little, Jianhua Zhang, Sreyashi Basu, Marina Y Konopleva, Mario L Marques-Piubelli, Luisa Maren Solis Soto, Edwin Roger Parra Cuentes, Wei Lu, Auriole Tamegnon, Guillermo Garcia Manero, Michael R Green, Padmanee Sharma, James P Allison, Steven Mitchell Kornblau, Kunal Rai, Linghua Wang, Naval Daver, P Andrew Futreal
Single cell T cell landscape and T cell receptor repertoire profiling of AML in context of PD-1 blockade therapy. Nature communications 12 (1) (2021)